Patent · US Active

Fused heterocyclic compound

US10981934B2 · kind B2 · utility

1Cited by
2References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 25, 2019
Grant dateApr 20, 2021
Priority date—
Expiry dateOct 25, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided is a compound represented by the following formula, or a salt thereof: [wherein each symbol is as defined herein.].

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.